Several interesting presentations so far at the EASD; an interesting Claude Bernard lecture given by Professor Stephen Kahn from University of Washington, summing up his more than 30 years of research studying the pathophysiology of type 2 diabetes. Please see the webcast for his very good lecture.
Some of the other highlights (of course omitting the most), are: Heavily debates on the role of SGLT-2 inhibitors in type 1 diabetes, the importance of type 2 diabetes in the paediatric population (not only small adults!), status for beta-cell replacement therapy, the importance of heart failure, renal failure and the combination of the two in diabetes, Imeglimin: a new principle for glucose lowering treatment, the many faces of bariatric surgery, new biomarkers for diabetic nephropathy, and many, many more. I recommend to log in and follow the webcasts.
On Wednesday several presentations from our research center created attention:
Anh Thi Tran